| Literature DB >> 35282571 |
Margi Parikh1, Karkala Venkappa Kishan2, Nimisha Chinmay Shah2, Maitry Parikh1, Purnima Saklecha2.
Abstract
Aim: The study was designed to clinically evaluate biodentine and endosequence root repair material (ERRM) as direct pulp capping agent at 3 months, 6 months, and 12 months intervals. Materials andEntities:
Keywords: Clinical study; pain; pulp capping; tricalcium silicate
Year: 2022 PMID: 35282571 PMCID: PMC8896135 DOI: 10.4103/jcd.jcd_321_21
Source DB: PubMed Journal: J Conserv Dent ISSN: 0972-0707
Figure 1Representative case of Biodentine group: (a) Preoperative clinical photograph, (b) Exposure of pulp, (c) Placement of Biodentine over the exposure site, (d) Evaluation after 6 months and restoration with resin-modified Glass ionomer cement (GIC) as base and Final restoration with Composite. Representative case of Endosequence Root Repair material group: (e) Preoperative clinical photograph, (f) Exposure of pulp, (g) Placement of Endosequence Root Repair material over the exposure site, (h) Evaluation after 6 months and Final restoration with Composite
Figure 2Flow chart of the subjects included and their progress throughout all the phases of study
Chisquare tests for clinical evaluation for comparison of the two groups
| GROUP | Percussion Test | Heat test | Cold test | Electric test | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| baseline | 3 months | 6 months | 12 months | baseline | 3 months | 6 months | 12 months | baseline | 3 months | 6 months | 12 months | Baseline | 3 months | 6 months | 12 months | |||
| GROUP A | POSITIVE | 0 (0) | 0 (0) | 0 (0) | 0 (0) | VITAL | 28 (100) | 22 (91.70) | 21 (100) | 21 (100) | 30 (100) | 22 (91.70) | 21 (100) | 0 (21 (100) | 30 (100) | 22 (91.70) | 21 (100) | 21 (100) |
| NEGATIVE | 30 (100) | 21 (100) | 21 (100) | 21 (100) | NON VITAL | 0 (0) | 2 (8.30) | 0 (0) | 0 (0) | 0 (0) | 2 (8.30) | 0 (0) | 0 (0) | 0 (0) | 2 (8.30) | 0 (0) | 0 (0) | |
| GROUP B | POSITIVE | 0 (0) | 0 (0) | 0 (0) | 0 (0) | VITAL | 30 (100) | 19 (100) | 19 (100) | 17 (100) | 30 (100) | 19 (95.00) | 19 (100) | 17 (100) | 30 (100) | 19 (95.00) | 19 (100) | 17 (100) |
| NEGATIVE | 30 (100) | 25 (100) | 21 (100) | 17 (100) | NON VITAL | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5.00) | 0 (0) | 0 (0) | 0 (0) | 1 (5.00) | 0 (0) | 0 (0) | |
| Chi - square | 1.661 | 0.191 | 0.191 | |||||||||||||||
|
| 0.198 | 0.662 | 0.662 | |||||||||||||||
Graph 1Postoperative pain assessment